PFE Financial Facts

Other deductions--net: -43M
Cost of sales: 2.41B
See Full Income Statement

Total liabilities and shareholders' equity: -370.15B
Accumulated other comprehensive loss: 15.73B
See Full Balance Sheet

Pfizer Inc. (PFE) Earnings

  |   Expand Research on PFE
Next EPS Date 5/5/14 EPS Growth Rate +3.7%
Average EPS % Beat Rate +2.8% Revenue Growth Rate -10.1%
Average % Move 1-Wk after EPS -0.5% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. % Since Details
1/29/13 Q412 $0.47$0.44 +$0.03$15.1B$14.4B = +12.6% Details
2/1/11 Q410 $0.47$0.46 +$0.01$17.56B$16.97B = +65.9% Details
1/31/12 Q411 $0.50$0.47 +$0.03$16.7B$16.61B = +40.1% Details
11/2/10 Q310 $0.54$0.51 +$0.03N/AN/A N/A +71.6% Details
1/28/14 Q413 $0.56$0.52 +$0.04$13.56B$13.35B = +1.9% Details
11/1/12 Q312 $0.53$0.53 $0.00$14B$14.64B = +21.6% Details
7/31/12 Q212 $0.62$0.54 +$0.08$15.1B$14.9B = +27.5% Details
11/1/11 Q311 $0.62$0.55 +$0.07$3.74B$16.43B = +57% Details